10 As shown in FIGURE 3 , exenatide normalizes blood glucose levels by reducing fasting and postprandial glucose concentrations through a variety of mechanisms, including enhanced glucose-dependent insulin secretion, regulation of glucagon secretion, delayed gastric emptying, and decreased food intake due to centrally mediated effects on satiety
However, potential side effects of branded GLP-1s are well-documented and must be disclosed according to FDA regulations
Other commercially available shakes deliver approximately 30 grams of protein with lower sugar content, though some formulations contain artificial sweeteners that may not suit all patients
Now Smith, Kline, and French wanted to craft a narrative that obesity was a disease of the mind, not the body, because they were trying to find a new market for one of their existing drugs